Pyrazinyl amide T-type calcium channel antagonists

Details for Australian Patent Application No. 2008317351 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Barrow, James C.; Yang, Zhi-Qiang

Agent Spruson & Ferguson

Pub. Number AU-A-2008317351

PCT Pub. Number WO2009/054982

Priority 61/000,163 24.10.07 US

Filing date 23 October 2008

Wipo publication date 30 April 2009

International Classifications

A61K 31/4965 (2006.01) - Non-condensed pyrazines

Event Publications

29 April 2010 PCT application entered the National Phase

  PCT publication WO2009/054982 Priority application(s): WO2009/054982

1 November 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008317352-Heterocycle amide T-type calcium channel antagonists

2008317348-System and method for assigning responsibility for trade order execution